CN102940831A - 一种用于抑菌与治疗妇科炎症的外用泡腾片 - Google Patents
一种用于抑菌与治疗妇科炎症的外用泡腾片 Download PDFInfo
- Publication number
- CN102940831A CN102940831A CN2012104791879A CN201210479187A CN102940831A CN 102940831 A CN102940831 A CN 102940831A CN 2012104791879 A CN2012104791879 A CN 2012104791879A CN 201210479187 A CN201210479187 A CN 201210479187A CN 102940831 A CN102940831 A CN 102940831A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- effervescent tablet
- fructus
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 30
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 30
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 29
- 230000002401 inhibitory effect Effects 0.000 title abstract description 9
- 241000894006 Bacteria Species 0.000 title abstract description 7
- 241000046691 Daphne odora Species 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 9
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 241000545442 Radix Species 0.000 claims description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 8
- 235000006226 Areca catechu Nutrition 0.000 claims description 8
- 244000080767 Areca catechu Species 0.000 claims description 7
- 244000269722 Thea sinensis Species 0.000 claims description 7
- 241001071795 Gentiana Species 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 3
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 238000004380 ashing Methods 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 229940116229 borneol Drugs 0.000 claims description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000010985 leather Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 230000002147 killing effect Effects 0.000 abstract description 8
- 244000052616 bacterial pathogen Species 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 206010046914 Vaginal infection Diseases 0.000 abstract description 4
- 201000008100 Vaginitis Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000235603 Acacia catechu Species 0.000 abstract description 2
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 235000006020 Acacia catechu Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 241000723353 Chrysanthemum Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 208000002003 vulvitis Diseases 0.000 abstract 1
- 206010007247 Carbuncle Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 238000012790 confirmation Methods 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 201000004624 Dermatitis Diseases 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 7
- 206010063409 Acarodermatitis Diseases 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 241000447727 Scabies Species 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 208000005687 scabies Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000517304 Pthirus pubis Species 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 206010014881 enterobiasis Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- NNPDNNXUSPXBRO-UHFFFAOYSA-N 3-hydroxy-1-(4-hydroxyphenyl)-5-phenylpentan-1-one Chemical compound C=1C=C(O)C=CC=1C(=O)CC(O)CCC1=CC=CC=C1 NNPDNNXUSPXBRO-UHFFFAOYSA-N 0.000 description 1
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 1
- JRHMMVBOTXEHGJ-UHFFFAOYSA-N daphnoretin Chemical compound C1=CC(=O)OC2=CC(OC3=CC=4C=C(C(=CC=4OC3=O)O)OC)=CC=C21 JRHMMVBOTXEHGJ-UHFFFAOYSA-N 0.000 description 1
- UJRSXAFBORHKBS-UHFFFAOYSA-N daphnoretin Natural products COC1=CC2C=C(Oc3ccc4C=CC(=O)Oc4c3)C(=O)OC2C=C1O UJRSXAFBORHKBS-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- LFBIHCZSRPAPHS-UHFFFAOYSA-N rutamontine Natural products COc1cc2OC(=O)C(=Cc2cc1O)Oc3ccc4C=CC(=O)Oc4c3 LFBIHCZSRPAPHS-UHFFFAOYSA-N 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于抑菌与治疗妇科炎症的外用泡腾片,属中药领域。本发明泡腾片有效成分的原料组成及重量份数为:苦参55~75份、大黄50~70份、百部50~65份、黄柏45~65份、黄芩45~60份、龙胆草40~60份、蛇床子40~55份、黄莲35~55份、茯苓35~50份、儿茶30~50份、白芷30~45份、枯矾25~45份、瑞香20~40份、野菊花15~35份、吴茱萸10~30份、冰片4~25份。本发明各选材药理协同,君药杀菌,臣药益中,左使相合,清热燥湿,活气益血,有治病求本、标本兼治之功效,吸收效果好,疗效显著,安全可靠,无毒副作用及临床不良反应,经临床验证对女性外阴炎、阴道炎常见致病菌有较强的抑菌能力,对各类妇科炎症的治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于抑菌与治疗妇科炎症的外用泡腾片。
背景技术
妇科炎症是女性的常见疾病,主要是指女性生殖器官的炎症,具体包括女性外阴炎、阴道炎、宫颈炎、盆腔炎,通常是由病原微生物感染而引起,症状表现为白带异常、异味,以及偶尔的出血症状。
在临床中,目前对各类妇科炎症的治疗方法,通常是首先确定引发炎症的致病菌,针对致病菌选用不同的抗生素口服或静脉注射,疗效较好。但由于妇科炎症的特殊性,往往会因为用药不规范、患者认为症状消失意味着痊愈、与性对象的相互交叉感染、过量服用抗生素或患有糖尿病、卫生防护措施不到位等原因,造成妇科炎症的反复发作、频繁发作、多种炎症并发等问题。
由于妇科炎症发作时,除白带异常、异味等症状外,通常还伴随着强烈的瘙痒感,患者痛苦异常。现代医学采用抗生素针对性治疗的方法,要解决的杀灭致病菌的问题,对患者难以忍受的瘙痒感无能为力,患者一般只能采用洗液进行局部冲洗、擦洗予以缓解。而目前市售的多种洗液,大多采用富含抗生素的配方,容易造成抗生素的过量使用。
目前常见的中医配方洗液,配方选药、药材炮制方法较为保守,尤其是对一些具有小毒、中毒的药材,如枯矾、冰片等药材,一般弃而不用,导致治疗效果有限且不持久,现有中药配方的洗液通常需要患者抓药后自行煎制,煎制及治疗过程费时费力,给患者带来了极大的麻烦。。
此外,传统中医对某些药材的特定药用价值缺乏认识,比如瑞香,一般认为可用于风湿性关节炎、坐骨神经痛、咽炎、牙痛、乳腺癌初起、跌打损伤,却忽视了其极强的尿酸排泄作用可有效辅助妇科炎症的治疗。
发明内容
本发明提供了一种用于抑菌与治疗妇科炎症的外用泡腾片,具有清热燥湿,活气益血、标本兼治、使用方便的特点,能广泛杀灭各类妇科炎症的致病菌,具有很好的妇科炎症防治疗效。
为实现上述目的,本发明的技术方案实施如下:
一种用于抑菌与治疗妇科炎症的外用泡腾片,制成所述泡腾片有效成分的原料组成及重量份数为:
苦参55~75份 大黄50~70份 百部50~65份 黄柏45~65份
黄芩45~60份 龙胆草40~60份 蛇床子40~55份 黄莲35~55份
茯苓35~50份 儿茶30~50份 白芷30~45份 枯矾25~45份
瑞香20~40份 野菊花15~35份 吴茱萸10~30份 冰片4~25份
制成所述泡腾片有效成分的原料组成及重量份数为:
苦参58~73份 大黄52~67份 百部53~63份 黄柏47~62份
黄芩48~58份 龙胆草43~55份 蛇床子42~52份 黄莲38~53份
茯苓38~48份 儿茶32~47份 白芷32~42份 枯矾28~43份
瑞香23~38份 野菊花17~32份 吴茱萸13~27份 冰片6~18份
制成所述泡腾片有效成分的原料组成及重量份数为:
苦参62份 大黄57份 百部55份 黄柏52份
黄芩50份 龙胆草48份 蛇床子45份 黄莲42份
茯苓40份 儿茶35份 白芷34份 枯矾32份
瑞香28份 野菊花23份 吴茱萸15份 冰片8份
一种用于抑菌与治疗妇科炎症的外用泡腾片的制备方法,包括以下工艺步骤:
(1)将黄柏用文火炒至微黄,置荫凉处风干后研为细末,过100目筛网得细粉,备用。
(2)将龙胆草烧灰,枯矾、冰片研末,将龙胆草灰、枯矾粉末、冰片粉末放入容器中,加入一倍量的陈醋,加热蒸发醋液至混合物呈半干状态,备用。
(3)将百部、蛇床子放入容器中,加入三倍量的即墨老酒,浸泡6~8小时后,过滤,取液;在剩余的残渣中再加入两倍量的即墨老酒,浸泡4~6小时,过滤,取液;在剩余的残渣中再加入一倍量的即墨老酒,浸泡2~3小时,过滤,取液;合并三次取得的浸泡液,完全干燥结块后研成粉末,过100目筛网得细粉,备用。
(4)将苦参、大黄、黄芩、黄莲、茯苓、儿茶、白芷、瑞香、野菊花、吴茱萸放入容器中,加入四倍量的水,浸泡4~6小时,过滤,取液;在剩余的残渣中再加入两倍量的水,浸泡2~3小时,过滤,取液;合并两次取得的浸泡液,浓缩成60℃环境下相对密度1.15~1.25的稠膏。
(5)将步骤(1)和步骤(3)中所得的细粉、步骤(2)中所得的半干混合物与步骤(4)制得的稠膏混合,搅拌均匀,于45~50℃蒸发干燥后,以现代机械工艺制备成3g/粒的泡腾片。
本发明所用中药的药性如下:
苦参:味苦;性寒。入肝;肾;大肠;小肠;膀胱;心经。清热燥湿;祛风杀虫。主治湿热泻痢;肠风便血;黄疸;小便不利;水肿;带下;阴痒;疥癣;麻风;皮肤瘙痒;湿毒疮疡。《名医别录》载:“养肝胆气,安五脏,定志益精,利九窍,除伏热肠游,止渴,醒酒,小便黄亦,疗恶疮下部疡,平胃气,令人嗜食。”现代医学研究证实,苦参能有效杀灭各类真阴,对女性外阴炎、阴道炎常见致病菌具有较强的抑菌能力,对阴道粘膜的白色念珠菌具有显著抑制作用,此外还有较强的抗炎、止痒和增强细胞免疫的功能。
大黄:味苦;性寒。入胃;大肠;肝;脾经。攻积滞;清湿热;泻火;凉血;祛瘀;解毒。主治实热便秘;湿热泻痢;淋病;水肿腹满;小便不利;衄血;便血;产后瘀滞腹痛;癓瘕积聚;热毒痈疡。《日华子本草》载:“通宣一切气,调血脉,利关节,泻壅滞、水气,四肢冷热不调,温瘴热痰,利大小便,并敷一切疮疖痈毒。”现代医学研究证实,大黄具有广谱抗病毒、抗菌和抗霉菌的作用,可用于各种炎症的防治,大黄的有效成分能消除氧自由基,抑制脂质过氧化,具有抗衰老作用,此外还具有突出的调节免疫功能,对泌尿系统疾病有很明显的预防及治疗作用。
百部:性甘、苦,微温。入肺经。润肺下气止咳,可有效杀灭头虱、体虱,功能主治蛲虫病、阴部瘙痒。《本草拾遗》载:“火炙浸酒空腹饮,去虫蚕咬,兼疥癣疮。”现代医学研究证实,百部煎剂及醇浸液对多种致病菌有抑制和杀灭作用,醇浸液对头虱和阴虱有极强的杀灭药性。
黄柏:味苦;性寒。入肾;膀胱经。清热燥湿;泻火解毒。主治湿热痢疾、泄泻、黄疸;梦遗、淋浊、带下;骨蒸劳热;痈疽疮毒;皮肤湿疹。《药品化义》载:“降火能自顶至踵,沦肤彻髓,无不周到,专泻肾与膀胱之火。”现代医学研究证实,黄柏含小蘖碱、黄柏酮等主要成分,有抗菌、收敛、消炎的作用,对各种皮肤湿毒、疮疡等症状,功效良好。
黄芩:味辛;苦;性寒。归肺;肝;肾经。清热解毒;散瘀止血;利尿消肿。主治热毒痈肿;咽喉疼痛;肺痈;肠痈;瘰疬;吐血;衄血;血淋;水肿;腹水及癌症。《泉州本草》载:“清热,解毒,法风,散血,行气,利水,通络,破瘀,止痛。内服主血淋,吐血,衄血;外用冶毒蛇咬伤,痈疽,疔疮,无名肿毒。”现代医学研究证实,黄芩具有广谱抗菌作用,此外还有抗血小板聚集、抗凝以及降血脂的作用。
龙胆草:味苦;性寒。入心;肺;胃;大肠经。清热利湿;凉血解毒。主治痢疾;便血;小便不利;产褥热;疳积;疮疡;肿毒。《常用中草药手册》载:“清热,除湿,解毒,止痛,健胃。治药毒,发痧肚痛,腰痛,子宫内膜炎,黄疸,胃痛,消化不良。”现代医学研究证实,龙胆草能明显降低血清胆红素含量,对绿脓杆菌,变形杆菌,伤寒杆菌,痢疾杆菌,金黄色葡萄球菌均有不同程度的抑制作用,此外还具有利尿、镇痛、镇静和抗变态反应的功能。
蛇床子:味辛;苦;性温;有小毒。归脾;肾经。温肾壮阳;燥湿杀虫;祛风止痒。主治女子宫寒不孕;寒湿带下;阴痒肿痛;风湿痹痛;湿疮疥癣。《本草经疏》载:“温中下气,能除湿,散寒,润肾,益脾,除一切虚寒湿病。”现代医学研究证实,蛇床子含多种挥发油、蛇床酚、香柑内酯、蛇床子素、香豆类成分及棕榈酸等,具有性激素样作用,能使体内环核苷酸和前列腺素恢复正常。此外,还有抗微生物、寄生虫、杀灭阴道滴虫、抑制絮状表皮癣菌的功效。
黄莲:味苦;性寒。归心;脾;胃;肝;胆;大肠经。清热燥湿;泻火争毒。用于湿热痞满;泻痢;心烦不寐;血热吐衄;消渴;痈肿疔疮;外治湿疹;湿疮;耳道流脓。现代医学研究证明,黄连有较强的抗微生物及抗原虫作用,可降低血溏,抗血小板聚集及溶栓,此外对鼻咽癌和宫颈癌也有抑制作用。
茯苓:味甘;淡;性平。入心;脾;肺;肾经。渗湿利水;宁心安神。主治小便不利;水肿胀满;泄渲;遗精白浊。《别录》载:“止消渴,好睡,大腹,淋沥,膈中痰水,水肿淋结。开胸腑,调脏气,伐肾邪,长阴,益气力,保神守中。”现代医学研究证实,茯苓对金黄色葡萄球菌、大肠杆菌、变形杆菌等均有抑制作用,能杀死钩端螺旋体等细菌,对泌尿系统、血液系统及中枢神经系统具有一定的保护作用,此外茯苓聚糖含量很高,可抗肿瘤活性。
儿茶:味苦;涩;性凉;无毒。入心;肺经。收湿敛疮,止血定痛,清热化痰。主治疮疡;久溃不敛;湿疮流水;牙疳;口疮;咯血;吐血;尿血;便血;血崩;痔疮痈肿。《本草正》载:“降火生津,清痰涎咳嗽,治口疮喉痹,烦热,止消渴,吐血,衄血,便血,尿血,湿热痢血,及妇人崩淋,经血不止,小儿疳热,口疮,热疮,湿烂诸疮,敛肌长肉,亦杀诸虫。”现代医学研究证实,儿茶富含的茶多糖通过口服吸收进入血液循环,激活人体胰岛素促使其恢复生物活性,能使血糖平稳下降,控制癌细胞发作,同时对多种致病细菌有较强的除灭功效。
白芷:味辛;性温。归肺;脾;胃经。祛风除湿;通窍止痛;消肿排脓。主治湿胜久渲;妇女白带;痈疽疮疡。《日华子本草》载:“治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面庞疵瘢。”现代医学研究证实,白芷对祛斑有显著的作用,能改善局部血液循环,此外还有解热、镇痛、抗炎等作用,尤其是对阴虱和各类外阴致病菌有杀除作用。
枯矾:味酸;涩;性寒;有毒。入肺;脾;胃;大肠经。燥湿;解毒;杀虫。主治癫痫;疚涎壅甚;子宫脱垂;白带;泻痢;衄血;疮痔疥癣;水、火、虫伤。《纲目》载:“吐下痰涎饮磷,燥湿解毒,追涎,止血定痛,蚀恶肉,生好肉,治痈疽疔肿,恶疮,癫痫,疸疾,通大小便,口齿眼目诸病,虎犬蛇蝎百虫伤。”现代医学研究证实,枯矾能强力凝固蛋白质,具有广谱抗菌功效,对多种革兰氏阳性球菌和阴性杆菌、某些厌氧菌、皮肤癣菌、白色念珠菌均有不同程度的抑制作用,对绿脓杆菌、大肠杆菌、金黄色葡萄球菌抑制明显,可明显抗阴道滴虫,此外还有止血和促进溃疡愈合的作用。
瑞香:味辛;甘;性温。祛风除湿;活血止痛。《现代实用中药》载:“敷疮疡,消肿止痛,治疮疡。”现代医学研究证实,瑞香含瑞香黄烷素、瑞香醇酮、瑞香素、西瑞香素、伞形花内酯、瑞香新素,可降低血液凝固性,延长血块形成时间,促进体内尿酸排泄,有效提高妇科炎症的治疗效果。
野菊花:味苦;辛;性平。入肺;肝经。清热解毒;疏风平肝。主治疗疮;痈疽;丹毒;湿疹;皮炎;咽喉肿痛。《本草汇言》载:“破血疏肝;解疔散毒。主妇人腹内宿血,解天行火毒丹疔。洗疮疥,又能去风杀虫。”现代医学研究证实,野菊花具有广谱抗菌作用,对多数皮肤真菌、金黄色葡萄球菌、痢疾杆菌、绿脓杆菌和流感病毒均有较强的抑制作用,还具有降压、降脂的作用。
吴茱萸:味辛;苦;性热;小毒。入肝;胃;脾;大肠;肾经。散寒止痛;疏肝下气;温中燥湿。主治脘腹冷痛;厥阴头痛;疝痛;寒湿泄泻。《本草纲目》载:“开郁化滞。治吞酸,厥阴痰涎头痛,阴毒腹痛,疝气,血痢,喉舌口呛。”现代医学研究证实,吴茱萸有止泻,抗溃疡,升血压,抗休克,改善微循环,提高免疫功能,同时对阴道炎的多种致病菌有一定的杀灭作用。
冰片:味辛;苦;性凉。入心;肺经。开窍醒神;散热止痛;明目去翳。主治中风口噤;热病神昏;惊痫痰迷;气闭耳聋;目赤翳膜;喉痹;口疮;痈肿;痔疮;蛲虫病。《本草正》载:“味微甘大辛,敷用者其凉如冰,而气雄力锐。本非热,阳中有阴也。善散气,散血,散火,散滞,通窍,辟恶,逐心腹邪气。”现代医学研究证实,冰片可抑制或杀灭金黄色葡萄球菌、乙型溶菌性链球菌等5种常见细菌,冰片能有效促进其他药物透皮吸收的作用。
本发明与现有技术相比,具有以下有益效果:
本发明各选材药理协同,君药杀菌、臣药益中,左使相合,清热燥湿,活气益血,有治病求本、标本兼治之功效,吸收效果好,疗效显著,安全可靠,无毒副作用及临床不良反应,经临床验证对女性外阴炎、阴道炎常见致病菌有较强的抑菌能力,对各类妇科炎症的治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明泡腾片有效成分的原料组成及重量为:
苦参68g 大黄64g 百部60g 黄柏58g
黄芩55g 龙胆草53g 蛇床子51g 黄莲48g
茯苓45g 儿茶43g 白芷40g 枯矾37g
瑞香34g 野菊花29g 吴茱萸22g 冰片12g
本发明泡腾片制备方法的工艺步骤为:
(1)将黄柏用文火炒至微黄,置荫凉处风干后研为细末,过100目筛网得细粉,备用。
(2)将龙胆草烧灰,枯矾、冰片研末,将龙胆草灰、枯矾粉末、冰片粉末放入容器中,加入一倍量的陈醋,加热蒸发醋液至混合物呈半干状态,备用。
(3)将百部、蛇床子放入容器中,加入三倍量的即墨老酒,浸泡6~8小时后,过滤,取液;在剩余的残渣中再加入两倍量的即墨老酒,浸泡4~6小时,过滤,取液;在剩余的残渣中再加入一倍量的即墨老酒,浸泡2~3小时,过滤,取液;合并三次取得的浸泡液,完全干燥结块后研成粉末,过100目筛网得细粉,备用。
(4)将苦参、大黄、黄芩、黄莲、茯苓、儿茶、白芷、瑞香、野菊花、吴茱萸放入容器中,加入四倍量的水,浸泡4~6小时,过滤,取液;在剩余的残渣中再加入两倍量的水,浸泡2~3小时,过滤,取液;合并两次取得的浸泡液,浓缩成60℃环境下相对密度1.15~1.25的稠膏。
(5)将步骤(1)和步骤(3)中所得的细粉、步骤(2)中所得的半干混合物与步骤(4)制得的稠膏混合,搅拌均匀,于45~50℃蒸发干燥后,以现代机械工艺制备成3g/粒的泡腾片。
用法用量:每日2次,早晚各一次,每次1粒,以热开水冲泡,取其热气熏蒸、药液擦洗外阴部,3天为一个疗程,通常1~2个疗程有效,顽症需3~4个疗程。
实施例2
本发明泡腾片有效成分的原料组成及重量为:
苦参65g 大黄61g 百部58g 黄柏56g
黄芩53g 龙胆草51g 蛇床子47g 黄莲45g
茯苓43g 儿茶39g 白芷37g 枯矾35g
瑞香30g 野菊花24g 吴茱萸18g 冰片10g
本实施例的泡腾片制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明泡腾片有效成分的原料组成及重量份数为:
苦参62g 大黄57g 百部55g 黄柏52g
黄芩50g 龙胆草48g 蛇床子45g 黄莲42g
茯苓40g 儿茶35g 白芷34g 枯矾32g
瑞香28g 野菊花23g 吴茱萸15g 冰片8g
本实施例的泡腾片制备方法工艺步骤及用法用量与实施例1相同。
临床资料
经临床跟踪数据显示,使用本发明所述外用泡腾片的142例患者中,98例患者妇科炎症完全康复且未再复发,35例患者的妇科炎症得到明显缓解和好转,总有效率达到94%,完全达到临床妇科炎症主治用药的要求。
Claims (4)
1.一种用于抑菌与治疗妇科炎症的外用泡腾片,其特征在于:制成所述泡腾片有效成分的原料组成及重量份数为:
苦参55~75份 大黄50~70份 百部50~65份 黄柏45~65份
黄芩45~60份 龙胆草40~60份 蛇床子40~55份 黄莲35~55份
茯苓35~50份 儿茶30~50份 白芷30~45份 枯矾25~45份
瑞香20~40份 野菊花15~35份 吴茱萸10~30份 冰片4~25份。
2.根据权利要求1所述的一种用于抑菌与治疗妇科炎症的外用泡腾片,其特征在于:制成所述泡腾片有效成分的原料组成及重量份数为:
苦参58~73份 大黄52~67份 百部53~63份 黄柏47~62份
黄芩48~58份 龙胆草43~55份 蛇床子42~52份 黄莲38~53份
茯苓38~48份 儿茶32~47份 白芷32~42份 枯矾28~43份
瑞香23~38份 野菊花17~32份 吴茱萸13~27份 冰片6~18份。
3.根据权利要求1所述的一种用于抑菌与治疗妇科炎症的外用泡腾片,其特征在于:制成所述泡腾片有效成分的原料组成及重量份数为:
苦参62份 大黄57份 百部55份 黄柏52份
黄芩50份 龙胆草48份 蛇床子45份 黄莲42份
茯苓40份 儿茶35份 白芷34份 枯矾32份
瑞香28份 野菊花23份 吴茱萸15份 冰片8份。
4.一种用于抑菌与治疗妇科炎症的外用泡腾片的制备方法,其特征在于:包括以下工艺步骤:
(1)将黄柏用文火炒至微黄,置荫凉处风干后研为细末,过100目筛网得细粉,备用。
(2)将龙胆草烧灰,枯矾、冰片研末,将龙胆草灰、枯矾粉末、冰片粉末放入容器中,加入一倍量的陈醋,加热蒸发醋液至混合物呈半干状态,备用。
(3)将百部、蛇床子放入容器中,加入三倍量的即墨老酒,浸泡6~8小时后,过滤,取液;在剩余的残渣中再加入两倍量的即墨老酒,浸泡4~6小时, 过滤,取液;在剩余的残渣中再加入一倍量的即墨老酒,浸泡2~3小时,过滤,取液;合并三次取得的浸泡液,完全干燥结块后研成粉末,过100目筛网得细粉,备用。
(4)将苦参、大黄、黄芩、黄莲、茯苓、儿茶、白芷、瑞香、野菊花、吴茱萸放入容器中,加入四倍量的水,浸泡4~6小时,过滤,取液;在剩余的残渣中再加入两倍量的水,浸泡2~3小时,过滤,取液;合并两次取得的浸泡液,浓缩成60℃环境下相对密度1.15~1.25的稠膏。
(5)将步骤(1)和步骤(3)中所得的细粉、步骤(2)中所得的半干混合物与步骤(4)制得的稠膏混合,搅拌均匀,于45~50℃蒸发干燥后,以现代机械工艺制备成3g/粒的泡腾片。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104791879A CN102940831A (zh) | 2012-11-23 | 2012-11-23 | 一种用于抑菌与治疗妇科炎症的外用泡腾片 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104791879A CN102940831A (zh) | 2012-11-23 | 2012-11-23 | 一种用于抑菌与治疗妇科炎症的外用泡腾片 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102940831A true CN102940831A (zh) | 2013-02-27 |
Family
ID=47723891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104791879A Pending CN102940831A (zh) | 2012-11-23 | 2012-11-23 | 一种用于抑菌与治疗妇科炎症的外用泡腾片 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940831A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922248A (zh) * | 2015-06-11 | 2015-09-23 | 吉林大学珠海学院 | 一种抗菌、消炎中药复方凝胶剂及制备方法 |
| CN105596531A (zh) * | 2016-01-30 | 2016-05-25 | 朱玉水 | 一种治疗妇科炎症的外用膏药及其制备方法 |
| CN105878438A (zh) * | 2016-06-02 | 2016-08-24 | 温红卫 | 一种用于治疗妇科炎症的中药丸剂及其制备方法 |
| CN108159043A (zh) * | 2018-03-20 | 2018-06-15 | 武汉轻工大学 | 西瑞香素在制药中的应用及药物制剂 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879831A (zh) * | 2006-05-17 | 2006-12-20 | 杨晋懿 | 用于抑菌与治疗妇科炎症的外用制剂及其制备方法 |
| CN101053612A (zh) * | 2007-02-16 | 2007-10-17 | 江西圣德维美药业有限公司 | 妇科外用的中药洁阴剂及其洁阴凝膏 |
| CN101612343A (zh) * | 2009-07-28 | 2009-12-30 | 杭州普瑞美克生物科技有限公司 | 一种治疗妇女阴道炎症的洗液 |
| CN101648003A (zh) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | 一种治疗妇科炎症的药物组合物及其用途 |
-
2012
- 2012-11-23 CN CN2012104791879A patent/CN102940831A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879831A (zh) * | 2006-05-17 | 2006-12-20 | 杨晋懿 | 用于抑菌与治疗妇科炎症的外用制剂及其制备方法 |
| CN101053612A (zh) * | 2007-02-16 | 2007-10-17 | 江西圣德维美药业有限公司 | 妇科外用的中药洁阴剂及其洁阴凝膏 |
| CN101648003A (zh) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | 一种治疗妇科炎症的药物组合物及其用途 |
| CN101612343A (zh) * | 2009-07-28 | 2009-12-30 | 杭州普瑞美克生物科技有限公司 | 一种治疗妇女阴道炎症的洗液 |
Non-Patent Citations (1)
| Title |
|---|
| 南京中医药大学: "《中药大辞典》", 31 March 2006, article "茯苓", pages: 2154 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922248A (zh) * | 2015-06-11 | 2015-09-23 | 吉林大学珠海学院 | 一种抗菌、消炎中药复方凝胶剂及制备方法 |
| CN104922248B (zh) * | 2015-06-11 | 2018-04-10 | 吉林大学珠海学院 | 一种抗菌、消炎中药复方凝胶剂及制备方法 |
| CN105596531A (zh) * | 2016-01-30 | 2016-05-25 | 朱玉水 | 一种治疗妇科炎症的外用膏药及其制备方法 |
| CN105878438A (zh) * | 2016-06-02 | 2016-08-24 | 温红卫 | 一种用于治疗妇科炎症的中药丸剂及其制备方法 |
| CN108159043A (zh) * | 2018-03-20 | 2018-06-15 | 武汉轻工大学 | 西瑞香素在制药中的应用及药物制剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
| CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
| CN101869626A (zh) | 中药复方制剂舒阴液及其制备与应用 | |
| CN100417403C (zh) | 治疗癌症的中药 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN102940831A (zh) | 一种用于抑菌与治疗妇科炎症的外用泡腾片 | |
| CN104117005A (zh) | 一种治疗热射病的中药制剂及其制备方法 | |
| CN103393857B (zh) | 一种治疗肝炎的药物及制备方法 | |
| CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
| CN104383384A (zh) | 一种治疗手足癣的中药洗液 | |
| CN105288071A (zh) | 一种用于痔疮治疗及术后护理的中药组方及制备方法 | |
| CN105194135A (zh) | 一种痔疮膏、制备方法及其应用 | |
| CN104922566A (zh) | 一种肛门洗剂及其制备方法 | |
| CN104288413A (zh) | 一种治疗小儿痢疾的中药组合物、其制备方法、制剂及应用 | |
| CN104258187A (zh) | 一种治疗尿路感染的中药制剂及制备方法 | |
| CN103495072A (zh) | 一种治疗支气管扩张病的中药组合物及其制备方法 | |
| CN102973744B (zh) | 一种用于混合型痔疮护理的外用药膏 | |
| CN104225256A (zh) | 一种治疗火毒内陷型烧伤的中药及制备方法 | |
| CN105343852A (zh) | 一种治疗慢性溃疡性结肠炎的药物及其制备方法 | |
| CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
| CN105031487A (zh) | 一种治疗湿困脾胃型小儿黄疸的中药组合物 | |
| CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
| CN103977279A (zh) | 一种治疗母猪子宫炎的中药添加剂及其制备方法 | |
| CN103417669B (zh) | 一种治疗腹痛、腹泻的药物 | |
| CN103055271B (zh) | 一种用于治疗慢性胃炎的药物及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130227 |